Effect of reducing the number of neoadjuvant chemoimmunotherapy cycles on clinical efficacy in locally advanced PD-L1 positive gastric cancer: A single center phase 2 study.Lingdi Zhao, Quanli Gao, Qiang Fu et al.|Journal of Clinical Oncology|2023Cited by 1
Neoadjuvant therapy using PD-1 inhibitor plus chemotherapy with different intervals between chemotherapy cycles for locally advanced gastric or gastroesophageal junction cancer: A randomized phase 2 study.Quanli Gao, Zhi Li, Lingdi Zhao et al.|Journal of Clinical Oncology|2024Cited by 0